Effects of pharmacologic androgen treatment duration on glucocorticoid receptor α immunoreactivity of lumbosacral motor neurons in the male rat

Neuroscience

Volumn 115, Issue 3, 2002, Pages 941-949

  Blanco, C E ^a   Peltz, A ^a   Staley, R ^a   Kim, F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anabolic androgenic steroids; Hippocampus; Neuromuscular systems; Testosterone propionate

Indexed keywords

ANDROGEN; CRYSTALLIN; GLUCOCORTICOID RECEPTOR; TESTOSTERONE; TESTOSTERONE PROPIONATE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; GENE CONTROL; GENE EXPRESSION; HINDLIMB; IMMUNOREACTIVITY; INFRARED RADIATION; INTRACELLULAR SPACE; LUMBOSACRAL SPINE; MALE; MOTONEURON; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; ANIMALS; CELL NUCLEUS; CYTOPLASM; GLUCOCORTICOIDS; HINDLIMB; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LUMBAR VERTEBRAE; MALE; MOTOR NEURONS; MUSCLE, SKELETAL; PELVIC FLOOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; SPINAL CORD;

EID: 0037049242     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00338-X     Document Type: Article

References (32)

1. Ahima R.S., Harlan R.E. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience. 39:1990;579-604.
2. Ahima R.S., Harlan R.E. Regulation of glucocorticoid receptor immunoreactivity in the rat hippocampus by androgenic-anabolic steroids. Brain Res. 585:1992;311-314.
3. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
4. Bhasin S., Storer T.W., Javanbakht M., Berman N., Yarasheski K.E., Phillips J., Dike M., Sinha-Hikim I., Shen R., Hays R.D., Beall G. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. J. Am. Med. Assoc. 283:2000;763-770.
5. Bigbee A.J., Gosselink K.L., Roy R.R., Grindeland R.E., Edgerton V.R. Bioassayable growth hormone release in rats in response to a single bout of treadmill exercise. J. Appl. Physiol. 89:2000;2174-2178.
6. Blanco C.E., Davenport T., Wachi S., Goedken T. Androgen receptor immunoreactivity of male rat cervical motor neurons is increased by chronic pharmacologic testosterone treatment. Acta Physiol. Pharmacol. Bulg. 26:2001;7-10.
7. Blanco, C.E., Goedken, T., Watts, J.R., Ner, A., Wachi, S., 2000. Circulating testosterone levels in the male rat modulate androgen receptor levels in motor neurons innervating the hindlimb. Neurosci. Abstr. 26, 541.511.
8. Blanco C.E., Popper P., Micevych P. Anabolic-androgenic steroid induced alterations in choline acetyltransferase messenger RNA levels of spinal cord motoneurons in the male rat. Neuroscience. 78:1997;873-882.
9. Blanco C.E., Zhan W.Z., Fang Y.H., Sieck G.C. Exogenous testosterone treatment decreases diaphragm neuromuscular transmission failure in male rats. J. Appl. Physiol. 90:2001;850-856.
10. Brownie A.C., Colby H.D., Gallant S., Skelton F.R. Some studies on the effect of androgens on adrenal cortical function of rats. Endocrinology. 86:1970;1085-1092.
11. Capaccio J.A., Kurowski T.T., Czerwinski S.M., Chatterton R.T. Jr., Hickson R.C. Testosterone fails to prevent skeletal muscle atrophy from glucocorticoids. J. Appl. Physiol. 63:1987;328-334.
12. Cintra A., Zoli M., Rosen L., Agnati L., Okret S., Wikstrom A., Gustafsson J., Fuxe K. Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience. 62:1994;843-897.
13. Claessens F., Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W. Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J. Steroid Biochem. Mol. Biol. 76:2001;23-30.
14. Cleutjens C.B., Steketee K., van Eekelen C.C., van der Korput J.A., Brinkmann A.O., Trapman J. Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells. Endocrinology. 138:1997;5293-5300.
15. De Vos P., Claessens F., Peeters B., Rombauts W., Heyns W., Verhoeven G. Interaction of androgen and glucocorticoid receptor DNA-binding domains with their response elements. Mol. Cell. Endocrinol. 90:1993;R11-R16.
16. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46:1986;645-652.
17. Ham J., Thomson A., Needham M., Webb P., Parker M. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acid Res. 16:1988;5263-5276.
18. Hickson R.C., Czerwinski S.M., Falduto M.T., Young A.P. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med. Sci. Sports Exerc. 22:1990;331-340.
19. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
20. Kerr J.E., Beck S.G., Handa R.J. Androgens modulate glucocorticoid receptor mRNA, but not mineralocorticoid receptor mRNA levels, in the rat hippocampus. J. Neuroendocrinol. 8:1996;439-447.
21. Kitraki E., Karandrea D., Kittas C. Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain. Neuroendocrinology. 69:1999;331-338.
22. Morimoto M., Morita N., Ozawa H., Yokoyama K., Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 26:1996;235-269.
23. Oakley R.H., Jewell C.M., Yudt M.R., Bofetiado D.M., Cidlowski J.A. The dominant negative activity of the human glucocorticoid receptor beta isoform: specificity and mechanisms of action. J. Biol. Chem. 274:1999;27857-27866.
24. Oakley R.H., Webster J.C., Jewell C.M., Sar M., Cidlowski J.A. Immunocytochemical analysis of the glucocorticoid receptor alpha isoform (GRalpha) using GRalpha-specific antibody. Steroids. 64:1999;742-751.
25. Oakley R.H., Webster J.C., Sar M., Parker C.R., Cidlowski J.A. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology. 138:1997;5028-5038.
26. Papka R.E., Storey-Workley M., Shughrue P.J., Merchenthaler I., Collins J.J., Usip S., Saunders P.T., Shupnik M. Estrogen receptor-alpha and beta-immunoreactivity and mRNA in neurons of sensory and autonomic ganglia and spinal cord. Cell Tissue Res. 304:2001;193-214.
27. Perhonen M., Takala T., Huttunen P., Leppaluoto J. Stress hormones after prolonged physical training in normo- and hypobaric conditions in rats. Int. J. Sports Med. 16:1995;73-77.
28. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
29. Simerly R., Chang C., Muramatsu M., Swanson L. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
30. Strawford A., Barbieri T., Neese R., Van Loan M., Christiansen M., Hoh R., Sathyan G., Skowronski R., King J., Hellerstein M. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. J. Acquired Immune Defic. Syndr. 20:1999;137-146.
31. Strawford A., Barbieri T., Van Loan M., Parks E., Catlin D., Barton N., Neese R., Christiansen M., King J., Hellerstein M.K. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. J. Am. Med. Assoc. 281:1999;1282-1290.
32. Yan P., Xu J., Li Q., Chen S., Kim G.M., Hsu C.Y., Xu X.M. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats. J. Neurosci. 19:1999;9355-9363.